• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶酸-聚乙二醇树枝状大分子与叶酸受体结合功能的结构分析

Structural analysis of binding functionality of folic acid-PEG dendrimers against folate receptor.

作者信息

Sampogna-Mireles Diana, Araya-Durán Ingrid D, Márquez-Miranda Valeria, Valencia-Gallegos Jesús A, González-Nilo Fernando D

机构信息

Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Col. Tecnológico, Monterrey, N.L, Mexico.

Universidad Andres Bello, Center for Bioinformatics and Integrative Biology (CBIB), Facultad de Ciencias Biológicas, Av. República 239, Santiago, Chile.

出版信息

J Mol Graph Model. 2017 Mar;72:201-208. doi: 10.1016/j.jmgm.2017.01.004. Epub 2017 Jan 6.

DOI:10.1016/j.jmgm.2017.01.004
PMID:28110184
Abstract

Dendrimers functionalized with folic acid (FA) are drug delivery systems that can selectively target cancer cells with folate receptors (FR-α) overexpression. Incorporation of polyethylene glycol (PEG) can enhance dendrimers solubility and pharmacokinetics, but ligand-receptor binding must not be affected. In this work we characterized, at atomic level, the binding functionality of conventional site-specific dendrimers conjugated with FA with PEG 750 or PEG 3350 as a linker. After Molecular Dynamics simulation, we observed that both PEG's did not interfere over ligand-receptor binding functionality. Although binding kinetics could be notably affected, the folate fragment from both dendrimers remained exposed to the solvent before approaching selectively to FR-α. PEG 3350 provided better solubility and protection from enzymatic degradation to the dendrimer than PEG 750. Also, FA-PEG3350 dendrimer showed a slightly better interaction with FR-α than FA-PEG750 dendrimer. Therefore, theoretical evidence supports that both dendrimers are suitable as drug delivery systems for cancer therapies.

摘要

用叶酸(FA)功能化的树枝状大分子是一种药物递送系统,它可以选择性地靶向过度表达叶酸受体(FR-α)的癌细胞。聚乙二醇(PEG)的加入可以提高树枝状大分子的溶解度和药代动力学,但不能影响配体-受体的结合。在这项工作中,我们在原子水平上表征了以PEG 750或PEG 3350作为连接体与FA共轭的传统位点特异性树枝状大分子的结合功能。经过分子动力学模拟,我们观察到两种PEG均未干扰配体-受体的结合功能。尽管结合动力学可能会受到显著影响,但两种树枝状大分子的叶酸片段在选择性接近FR-α之前仍暴露于溶剂中。与PEG 750相比,PEG 3350为树枝状大分子提供了更好的溶解度和对酶降解的保护。此外,FA-PEG3350树枝状大分子与FR-α的相互作用略优于FA-PEG750树枝状大分子。因此,理论证据支持这两种树枝状大分子都适合作为癌症治疗的药物递送系统。

相似文献

1
Structural analysis of binding functionality of folic acid-PEG dendrimers against folate receptor.叶酸-聚乙二醇树枝状大分子与叶酸受体结合功能的结构分析
J Mol Graph Model. 2017 Mar;72:201-208. doi: 10.1016/j.jmgm.2017.01.004. Epub 2017 Jan 6.
2
Substrate-Triggered Exosite Binding: Synergistic Dendrimer/Folic Acid Action for Achieving Specific, Tight-Binding to Folate Binding Protein.底物触发的别构位点结合:树枝状聚合物/叶酸协同作用以实现对叶酸结合蛋白的特异性紧密结合。
Biomacromolecules. 2016 Mar 14;17(3):922-7. doi: 10.1021/acs.biomac.5b01586. Epub 2016 Feb 3.
3
Revisiting the value of competition assays in folate receptor-mediated drug delivery.重新审视竞争分析在叶酸受体介导的药物递送中的价值。
Biomaterials. 2017 Sep;138:35-45. doi: 10.1016/j.biomaterials.2017.05.034. Epub 2017 May 22.
4
Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.基于Boltorn H40、聚(L-丙交酯)和聚(乙二醇)的叶酸共轭两亲性超支化嵌段共聚物用于肿瘤靶向给药
Biomaterials. 2009 Jun;30(16):3009-19. doi: 10.1016/j.biomaterials.2009.02.011. Epub 2009 Feb 27.
5
Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.具有 α-环糊精的叶酸-PEG 接枝树状聚合物缀合物作为新型的癌细胞选择性 siRNA 传递载体。
Mol Pharm. 2012 Sep 4;9(9):2591-604. doi: 10.1021/mp300188f. Epub 2012 Aug 9.
6
Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles.通过叶酸靶向树枝状大分子和 PEG-PLA 纳米粒的杂交实现细胞靶向的时空控制。
Biomacromolecules. 2012 Apr 9;13(4):1223-30. doi: 10.1021/bm300316n. Epub 2012 Mar 30.
7
Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles.叶酸靶向树枝状聚合物-聚合物杂化纳米颗粒的血液循环延长及肿瘤蓄积增强。
J Control Release. 2014 Oct 10;191:115-22. doi: 10.1016/j.jconrel.2014.05.006. Epub 2014 May 14.
8
Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug Release.上转换纳米晶-树枝状大分子复合材料的模块化集成用于叶酸受体特异性近红外成像和光触发药物释放。
Small. 2015 Dec 2;11(45):6078-90. doi: 10.1002/smll.201501575. Epub 2015 Oct 13.
9
Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system.叶酸功能化聚乙二醇化聚丙亚胺树枝状大分子的合成作为有前途的靶向药物传递系统。
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6513-7. doi: 10.1016/j.bmcl.2010.09.058. Epub 2010 Sep 16.
10
Breast Tumor Targeting with PAMAM-PEG-5FU-Tc As a New Therapeutic Nanocomplex: In In-vitro and In-vivo studies.聚酰胺-胺-聚乙二醇-5-氟尿嘧啶-铼作为一种新型治疗性纳米复合物用于乳腺癌靶向治疗的研究:在体外和体内研究。
Biomed Microdevices. 2020 Apr 25;22(2):31. doi: 10.1007/s10544-020-00485-5.

引用本文的文献

1
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles.受细胞外囊泡启发的新型仿生药物递送纳米颗粒
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jul-Aug;17(4):e70025. doi: 10.1002/wnan.70025.
2
Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy.纳米级生物偶联物:用于选择性癌症治疗的载药纳米载体偶联物的结构属性综述。
Heliyon. 2022 Jun 2;8(6):e09577. doi: 10.1016/j.heliyon.2022.e09577. eCollection 2022 Jun.
3
Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study.
接枝 β-环糊精增强叶酸与 FRα 的亲和力:分子动力学研究。
Molecules. 2021 Aug 31;26(17):5304. doi: 10.3390/molecules26175304.
4
Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications.用于药物递送应用的聚乙二醇化生物分子、脂质体和纳米颗粒的分子模拟
Pharmaceutics. 2020 Jun 10;12(6):533. doi: 10.3390/pharmaceutics12060533.